Related Experiment Video
Updated: Jun 17, 2026

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy
Published on: August 2, 2024
Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond
Lina Chen1, Sun-Mi Park, Jerrold R Turner
1Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois 60637, USA.
Abstract:
CD95 is a member of the death receptor family. It is a prototypical inducer of apoptosis that, upon binding of its cognate ligand (CD95L), forms a death-inducing signaling complex composed of adaptor molecules and initiator caspases that transmit the apoptosis signal. The CD95/CD95L system was implicated in the etiology of inflammatory bowel disease (IBD) based, primarily, on the finding that CD95 is highly expressed in the intestinal epithelial cells and that epithelial apoptosis is increased in IBD. In recent years it has been recognized that CD95, while playing an important role as an apoptosis-inducing receptor in the immune system, also has multiple nonapoptotic functions on nonimmune cells. This review critically discusses the data on the possible function of CD95 as an apoptosis-inducing receptor in IBD and discusses alternative mechanisms for epithelial cell loss in IBD.
Insights
The CD95/CD95L system
Area of Science:
- Immunology and Molecular Biology
- Gastroenterology and Cell Biology
Background:
- CD95 (death receptor) binding its ligand (CD95L) initiates apoptosis via a death-inducing signaling complex.
- The CD95/CD95L system is implicated in inflammatory bowel disease (IBD) due to high CD95 expression and increased epithelial apoptosis in IBD.
- Recent findings highlight CD95's non-apoptotic functions beyond immune cells.
Purpose of the Study:
- To critically review the role of CD95 as an apoptosis-inducing receptor in IBD.
- To explore alternative mechanisms contributing to epithelial cell loss in IBD.
Main Methods:
- Literature review and critical analysis of existing data.
- Examination of studies investigating CD95 expression and function in the context of IBD.
- Evaluation of evidence for both apoptotic and non-apoptotic roles of CD95.
Main Results:
- While CD95 is a known apoptosis inducer, its direct role in IBD pathogenesis via epithelial apoptosis is debated.
- Evidence suggests CD95 may have non-apoptotic functions in non-immune cells relevant to IBD.
- Alternative mechanisms for epithelial cell loss in IBD require further investigation.
Conclusions:
- The direct contribution of CD95-mediated apoptosis to epithelial cell loss in IBD may be less significant than previously thought.
- Non-apoptotic functions of CD95 in intestinal epithelial cells warrant further research in IBD.
- Understanding diverse CD95 functions is crucial for elucidating IBD etiology.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
The Extrinsic Apoptotic Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
